期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

β肾上腺素能受体阻滞剂治疗高血压的临床应用 被引量：7

原文传递
导出
摘要 β肾上腺素能受体阻滞剂（β受体阻滞剂）在高血压治疗领域的广泛应用已有三十多年的历史,大规模临床试验证明[1-5],β受体阻滞剂治疗高血压可明显降低致死和非致死性心血管事件的发生率,被国内外指南推荐为降压治疗的5大类降压药物之一[6-8]。
作者 党爱民
机构地区 中国医学科学院
出处 《中华高血压杂志》 CAS CSCD 北大核心 2011年第8期758-762,共5页 Chinese Journal of Hypertension
关键词 Β肾上腺素能受体阻滞剂 降压治疗 临床应用 高血压 Β受体阻滞剂 大规模临床试验 非致死性 心血管事件
分类号 R544.1 [医药卫生—心血管疾病]
  • 相关文献

参考文献25

  • 1J Wikstrand. Primary prevention in patients with hypertension comments on the clinical implications of the MAPHY study Metoprolol atheroselerosis prevention in hypertensives study[J] Am Heart J,1988,116(1/2) :338-347.
  • 2Johannesson M, Dahlof B, Lindholm LH, et al. The eosteffec- tiveness of treating hypertension in elderly people-an analysis of the Swedish trial in old patients with hypertension (STOP hypertension)[J]. J Intern Med, 1993,234(3) : 317-323.
  • 3UK prospective diabetes study group (UKDPS). Tight blood pressure control and risk of macrovascular and microvascular com- plications in type 2 diabetes: UKPDS 38 [J]. BMJ, 1998, 317 (7160):703-713.
  • 4Hansson L, Lindholm LH, Niskanen L, et al. Effect of angiotensin- converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the captopril prevention project (CAPPP) randomized trial [J]. Lancet, 1999,353(9153) : 611-616.
  • 5Hansson L, Lindholm LH, Ekbom T, et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish trial in old patients with hypertension-2 study[J]. Lancet, 1999,354(9192) : 1751-1756.
  • 6European society of hypertension-European society of cardiology guidelines committee. 2003 European society of hypertension-Eu- ropean society of cardiology guidelines for the management of arterial hypertension[J].J Hypertens. 2003.21 (6), 1011-1053.
  • 7Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint national committee on prevention, detection, evalution, and treatment of high blood pressure: the JNC 7 report[J]. JAMA, 2003,289 (19) : 2560-2572.
  • 8Lindholm LH, Carlberg B, Samuelsson O. Should β blockers remain first choice in the treatment of. primary hypertension? a meta-analysis[J]. LanCet,2005,366(9496) :1545-1553.
  • 92006 NICE/BHS guidelines of Hypertension-management of hypertension in adults in primary caret partial update[J].Monaldi Arch Chest Dis, 2006,66 (4): 238-240.
  • 10The task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC) 2007 guidelines for the management of arterial hypertension[J].J Hyperten,2007,25(6):1105-1187.

二级参考文献29

  • 1Mancia G. The sympathetic nervous system in hypertension[J]. J Hypertens,1997,15(12 Pt 2) :1553-1565.
  • 2Julius S, Nesbitt S. Sympathetic overactivity in hypertension. A moving target[J]. Am J Hypertens,1996,9(] l) : 113S-120S.
  • 3Schlaich MP, Lamber* E, Kaye DM, et al. Sympathetic augmen tation in hypertension: role of nerve firing, norepinephrine re- uptake, and Angiotensin neuromodulation [J]. ttypertension,2004,43(2) 169-175.
  • 4Julius S, Jamerson K, Mejia A, et al. The association of border line hypertension with target organ changes and higher coronary risk. Tecumseb blood pressure study[J]. JAMA,1990,264(3): 354-358.
  • 5Masuo K, MikamiH, OgiharaT, etal. Sympathetic nervehyper activity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population[J]. Am J Hypertens, 1997, 10(1) :77-83.
  • 6Esler M, Julius S, Zweifler A, etal. Mild high renin essential hy pertension. Neurogenic human hypertension? [J] New Engl J Med,1977,296(8) :405-411.
  • 7Pojoga L, Kolatkar NS, Williams JS, et al. Beta 2 adrenergic re eeptor diplotype defines a subset of salt-sensitive hypertension[J]. Hypertension, 2006,48 (5) : 892-900.
  • 8Pratt JH. The adrenergic nervous system conversing with the adrenal cortex: new implications for salt-sensitive hypertension[J]. Hypertension, 2006,48(5) : 820-821.
  • 9Wallukat G. The beta-adrenergic receptors[J]. Herz, 2002,27 (7) : 683-690.
  • 10Skeberdis VA. Structure and function of beta3-adrenergic receptors[J]. Medicina(Kaunas, Lithuania) ,2004,40(5) :407-413.

共引文献37

同被引文献65

引证文献7

二级引证文献24

中华高血压杂志
2011年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部